Bradykinin and prostaglandin E1 regulate calcitonin gene-related peptide expression in cultured rat sensory neurons

• Published in: Regulatory peptides 2011-02, Vol.167 (1), p.105-111
• Main Authors: Supowit, S.C., Zhao, H., Katki, K.A., Gupta, P., DiPette, D.J.
• Format: Article
• Language: English
• Subjects: Alprostadil - pharmacology; Animals; Biological and medical sciences; Bradykinin - pharmacology; Calcitonin Gene-Related Peptide - genetics; Calcitonin Gene-Related Peptide - metabolism; Cell Culture Techniques; Cell signaling; Cyclooxygenase Inhibitors - pharmacology; Dinoprostone - pharmacology; Dose-Response Relationship, Drug; Epoprostenol - pharmacology; Fundamental and applied biological sciences. Psychology; Ganglia, Spinal - drug effects; Ganglia, Spinal - metabolism; Ganglia, Spinal - secretion; Gene expression; Gene Expression - drug effects; Indomethacin - pharmacology; Inflammation; Male; Neuropeptides; Pain; Prostaglandin-Endoperoxide Synthases - metabolism; Rats; Rats, Sprague-Dawley; RNA, Messenger - analysis; RNA, Messenger - biosynthesis; Sensory nervous system; Sensory Receptor Cells - drug effects; Sensory Receptor Cells - metabolism; Sensory Receptor Cells - secretion; Time Factors; Vertebrates: endocrinology
• ISSN: 0167-0115; 1873-1686
• DOI: 10.1016/j.regpep.2010.12.006

Primary cultures of adult rat dorsal root ganglia (DRG) sensory neurons were used to determine whether bradykinin and prostaglandins E1 (PGE1), E2 (PGE2) or I2 (PGI2) stimulate long-term calcitonin gene-related peptide (CGRP) mRNA accumulation and peptide release. Treatment (24h) of neurons with either bradykinin or PGE1, significantly increased CGRP mRNA content and iCGRP release. However, PGE2 or PGI2 was without effect. Exposure of the cultured neurons to increasing concentrations of bradykinin or PGE1 demonstrated that the stimulation of CGRP expression was concentration-dependent, while time-course studies showed that maximal levels of CGRP mRNA accumulation and peptide release were maintained for at least 48h. Treatment of the neuronal cultures with a bradykinin B2 receptor antagonist significantly inhibited the bradykinin-induced increase in CGRP expression and release. In addition, preincubation of neuronal cultures with the cyclooxygenase inhibitor indomethacin did not alter the PGE1-mediated stimulation of CGRP but blocked completely the bradykinin-induced increase in CGRP production. Therefore, these data indicate that bradykinin and PGE1 can regulate the synthesis and release of CGRP in DRG neurons and that the stimulatory effects of bradykinin on CGRP are mediated by a cyclooxygenase product(s). Thus, these findings suggest a direct relationship between chronic alterations in bradykinin/prostaglandin production that may arise from pathophysiological causes and long-term changes in CGRP expression. ► BK and PGE1 stimulate long-term expression and release of CGRP in cultured DRG neurons. ► The effect of BK was mediated completely through the BK B2 receptor. ► The effect of BK was mediated by a cyclooxygenase product(s).